Abstract:Misfolded α-synuclein (αSyn) protein accumulates in 43-63% of individuals with symptomatic Alzheimer’s disease (AD). Two main patterns of co-morbid αSyn pathology have been identified: caudo-rostral and amygdala-predominant, with the latter being more common in AD. αSyn pathology has been shown to interact with DNA-binding protein 43 (TDP-43) and abnormally phosphorylated Tau protein (pTau). These proteins tend to accumulate in the amygdala, yet the specific role of amygdala-predominant αSyn pathology in the progression of AD and hippocampal degeneration remains unclear. In this cross-sectional study, we analyzed 291 autopsy brains from both demented and non-demented elderly individuals neuropathologically. Neuronal density in the CA1 region of the hippocampus was assessed using hematoxylin-stained sections for all cases. We semi-quantitatively evaluated αSyn pathology severity in six brain regions and stratified the cases into the two spreading patterns. In 99 AD cases, we assessed limbic-predominant age-related TDP-43 neuropathological changes (LATE-NC), CA1 pTau density, and cerebral amyloid angiopathy (CAA). Structural equation modeling analysis was conducted based on the assessed pathological parameters in AD patients. We identified an association between the amygdala-predominant αSyn pathology pattern and decreased neuronal density in the CA1 region. AD patients with an amygdala-predominant αSyn pattern exhibited the most severe pTDP-43 pathology among all groups, while those with the caudo-rostral pattern had the lowest severity of AD-related pathological changes including CAA type 1. Our model revealed that the relationship between αSyn pathology and CA1 neuron loss is mediated through pTau and LATE-NC. Our results indicate that amygdala-predominant αSyn pathology, in contrast to αSyn pathology with a caudo-rostral pattern, significantly contributes to hippocampal neuron loss, potentially by accelerating TDP-43 and pTau pathologies. This finding, along with observed neuropathological differences between AD patients with these two αSyn spreading patterns, underscores the need for precise stratification of patients. The stratification should consider not only the molecular and morphological identity of co-pathologies but also the distribution pattern of the respective co-pathologies.

A Multi-Layered Needle Injection Simulator

Alpha-synuclein fine-tunes neuronal response to pro-inflammatory cytokines

Neuroinflammation is associated with infiltration of T cells in Lewy body disease and α-synuclein transgenic models

RETRACTED: the Synergistic Effect Between Β-Amyloid1–42 and Α-Synuclein on the Synapses Dysfunction in Hippocampal Neurons

Intracranial tumours; a clinical review.

Bidirectional modulation of Alzheimer phenotype by alpha-synuclein in mice and primary neurons

The Synergistic Effect Study of Lipopolysaccharide (LPS) and A53T-α-Synuclein: Intranasal LPS Exposure on the A53T-α-Synuclein Transgenic Mouse Model of Parkinson's Disease

Templating of Monomeric Alpha-Synuclein Induces Inflammation and SNpc Dopamine Neuron Death in a Genetic Mouse Model of Synucleinopathy.

Role Of Pro-Inflammatory Cytokines Released From Microglia In Alzheimer'S Disease

The use of a break-even analysis: financial analysis of a fast-track program.

Impact of Alternating Amino Acid Sequences on Beta-Amyloid-induced Neurotoxicity and Neuroinflammation in Alzheimer's Disease.

The autoimmune response induced by α-synuclein peptides drives neuronal cell death and glial cell activation

Disease and brain region specific immune response profiles in neurodegenerative diseases with pure and mixed protein pathologies

Role of Pro-Inflammatory Cytokines Released from Microglia in Alzheimer's Disease.

Neuroinflammation and Oxidation/Nitration of Alpha-Synuclein Linked to Dopaminergic Neurodegeneration

Parkinson's disease-derived α-synuclein assemblies combined with chronic-type inflammatory cues promote a neurotoxic microglial phenotype

The A53T Mutation in α-Synuclein Enhances Proinflammatory Activation in Human Microglia Upon Inflammatory Stimulus

Amygdala-predominant α-synuclein pathology exacerbates hippocampal neuron loss in Alzheimer’s disease

Neuroinflammation and α-synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson's disease.

α-Synuclein-induced production of inflammatory mediators through Toll-like receptors in brain pericytes

Dysregulation of peripheral monocytes and pro-inflammation of alpha-synuclein in Parkinson's disease